LRFN2 and neoplasm: Tumor-intrinsic leucine-rich repeat and fibronectin type III domain-containing protein LRFN2 suppresses the recruitment and functional transformation of CD8+ T cells by reducing the secretion of pro-inflammatory cytokines and chemokines.